Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Keith Kullmann

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Frontiers in Cell and Developmental Biology|April 30, 2021
Stimulation of c-Jun/AP-1-Activity by the Cell Cycle Inhibitor p57<sup>Kip2</sup>Michael Keith Kullmann, Fragka Pegka, Christian Ploner, et al.
Scientific Reports|April 30, 2020
The CDK inhibitor p57<sup>Kip2</sup> enhances the activity of the transcriptional coactivator FHL2Michael Keith Kullmann, Silvio Roland Podmirseg, Martina Roilo, et al.
Leukemia|May 21, 2022
Inability to phosphorylate Y88 of p27<sup>Kip1</sup> enforces reduced p27 protein levels and accelerates leukemia progressionHeidelinde Jäkel, Martin Taschler, Karin Jung, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Frontiers in Cell and Developmental Biology|April 30, 2021
Stimulation of c-Jun/AP-1-Activity by the Cell Cycle Inhibitor p57<sup>Kip2</sup>Michael Keith Kullmann, Fragka Pegka, Christian Ploner, et al.
Scientific Reports|April 30, 2020
The CDK inhibitor p57<sup>Kip2</sup> enhances the activity of the transcriptional coactivator FHL2Michael Keith Kullmann, Silvio Roland Podmirseg, Martina Roilo, et al.
Leukemia|May 21, 2022
Inability to phosphorylate Y88 of p27<sup>Kip1</sup> enforces reduced p27 protein levels and accelerates leukemia progressionHeidelinde Jäkel, Martin Taschler, Karin Jung, et al.
Pageof 1